Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
VIDEO LIBRARIES
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging...
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging...
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging...
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging...
In this video series, GRACE Board Members Dr. H. Jack West, Dr. Jared Weiss, and Dr. Ben Levy have continued candid discussions regarding cancer and...
ARTICLES
2021 LIVE ONLINE Targeted Therapies Patient Forum July 17, 2021 10:00 AM Eastern Register Now! Join us once again for this highly anticipated annual...
GRACE is pleased to announce the acceptance of four rising stars into the third year of the GRACE Patient Education Ambassador Program for the 2021...
Sex is that one word that can mean and feel so different depending on the context of our lives. As young teenagers, the word may fill us with a sense...
2021 EN VIVO ONLINE Foro Español de Pacientes de Terapias Dirigidas 22 de julio de 2021 6:30 - 8:00 PM hora del este ¡Regístrate ahora! ¡La...
Online Community
A special thank you goes out to our sponsor Bristol-Myers Squibb for helping make the 2025 East Asian Lung Cancer Video Library possible!
A special thank you goes out to our sponsors Summit and Janssen for helping make the 2025 Lung Cancer Video Library possible!
A special thank you goes out to our sponsor Lilly Oncology for helping make the 2025 Blood Cancer Video Library possible!
A special thank you goes out to sponsors Bristol-Myers Squibb, Merck, Daiichi-Sankyo and AstraZeneca for helping make the 2025 Targeted Therapies in...
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.